Gene · 54890
Papers4,144
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 4,144
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Identification and validation of PANoptosis-related genes in ankylosing spondylitis. | BMC Med Genomics | 2026 | 41526902 | PubTator, text mining | PubMed |
| m6A modification and its clinical applications in gynaecological cancer. | Apoptosis | 2026 | 41518553 | PubTator, text mining | PubMed |
| (-)-Epicatechin Regulates Radioresistance in Lung Adenocarcinoma Through ALKBH5 Downregulation of FOXM1. | J Gene Med | 2026 | 41500820 | PubTator, text mining | PubMed |
| ALKBH5 Accelerates the Progression of Head and Neck Squamous Cell Carcinoma by Decreasing Methylation of the lncRNA NEAT1. | Appl Biochem Biotechnol | 2026 | 41484734 | PubTator, text mining | PubMed |
| The role of N6-methyladenosine associated genes in ischemic stroke risk: interplay with environmental factors. | J Thromb Thrombolysis | 2026 | 41466169 | PubTator, text mining | PubMed |
| ALKBH5 promotes inflammation and inhibits osteogenic differentiation by activating the TLR9/MAPK pathway in human periodontal ligament stem cells. | Cytotechnology | 2026 | 41458000 | PubTator, text mining | PubMed |
| Correlation of bioinformatics-based m6A methylation regulators with prognosis in oral squamous cell carcinoma patients. | J Craniomaxillofac Surg | 2026 | 41455610 | PubTator, text mining | PubMed |
| Epitranscriptomic modifications in embryonic development: insights into natural and ART-induced mechanisms and implications. | Hum Reprod Update | 2026 | 41445111 | PubTator, text mining | PubMed |
| Molecular Mechanism of the IRF1/NFE2L1-DT/ALKBH5/Cx43 Axis in Radiation-Induced Injury in Vascular Endothelial Cells Through Pyroptosis. | Kaohsiung J Med Sci | 2026 | 41439375 | PubTator, text mining | PubMed |
| The progress of m6A methylation-regulated non-coding RNAs in osteogenic differentiation and osteoporosis. | Noncoding RNA Res | 2026 | 41439031 | PubTator, text mining | PubMed |
| ALKBH5 promotes gastric cancer angiogenesis by stabilizing LncRNA PVT1 and VEGFA RNAs via m6A demethylation. | Mol Cell Biochem | 2026 | 41428170 | PubTator, text mining | PubMed |
| Epitranscriptomic regulation in cardiovascula disease: mechanistic roles and clinical implications of m6A RNA methylation in cardiac pathophysiology. | Curr Probl Cardiol | 2026 | 41422939 | PubTator, text mining | PubMed |
| A versatile type VI CRISPR-based approach for targeted m6A demethylation in mRNAs. | Genome Res | 2026 | 41381248 | PubTator, text mining | PubMed |
| Navigating the nexus: Dysregulation of non-coding RNAs in breast cancer under therapeutic interventions - Mechanisms and clinical implications. | Exp Cell Res | 2026 | 41380827 | PubTator, text mining | PubMed |
| circCNN2 drives endometrial cancer progression through ALKBH5/YTHDF2-mediated m6A regulation and miR-615-5p sponging. | Life Sci | 2026 | 41314596 | PubTator, text mining | PubMed |
| m6A modification erased by ALKBH5 promotes tumor growth and metastasis via regulation of YAP/ZEB1 axis in NSCLC. | Genes Dis | 2026 | 41216500 | PubTator, text mining | PubMed |
| Emerging Dual Roles of ALKBH5 in Ischemia-reperfusion Injury: Mechanisms and Therapeutic Implications. | Cell Biochem Biophys | 2026 | 41160375 | PubTator, text mining | PubMed |
| Reversible ALKBH5 cytosolic aggregation accelerates cellular senescence. | Cell Death Differ | 2026 | 40817288 | PubTator, text mining | PubMed |
| ALKBH5 modulates COL5A1 mRNA stability via m6A demethylation to promote tobacco carcinogen NNK-induced lung cancer occurrence and progression. | J Adv Res | 2026 | 40812588 | PubTator, text mining | PubMed |
| CD133-Guided RNA Nanoparticle Delivery of FTO siRNA Impairs Leukemia Resistance to Tyrosine Kinase Inhibitor Therapy. | RNA Nanomed | 2025 | 42004278 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/54890/papers?page=9